These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34383213)

  • 1. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review.
    AbdelHamid SG; Refaat AA; Benjamin AM; Elmawardy LA; Elgendy LA; Manolly MM; Elmaksoud NA; Sherif N; Hamdy NM
    Environ Sci Pollut Res Int; 2021 Oct; 28(39):54209-54221. PubMed ID: 34383213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review.
    Dey A; Vaishak K; Deka D; Radhakrishnan AK; Paul S; Shanmugam P; Daniel AP; Pathak S; Duttaroy AK; Banerjee A
    Infection; 2023 Dec; 51(6):1603-1618. PubMed ID: 36906872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020.
    Jammu AS; Chasen MR; Lofters AK; Bhargava R
    Support Care Cancer; 2021 Jun; 29(6):2841-2850. PubMed ID: 33242162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.
    Gomaa AA; Abdel-Wadood YA; Thabet RH; Gomaa GA
    Inflammopharmacology; 2024 Feb; 32(1):249-271. PubMed ID: 37957515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
    Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
    Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Immunomodulatory Nutrients in Alleviating Complications Related to SARS-CoV-2: A Scoping Review.
    Jandaghi P; Hosseini Z; Chilibeck P; Hanley AJ; Deguire JR; Bandy B; Pahwa P; Vatanparast H
    Adv Nutr; 2022 Mar; 13(2):424-438. PubMed ID: 34932789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine for the treatment of COVID-19.
    Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
    Di Maria E; Latini A; Borgiani P; Novelli G
    Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.